Industrials, Healthcare Jun 23, 2021 06:18 PM (GMT+8) · EqualOcean
Fosun Pharmaceutical announced that Fosun Kate, invested by the company, received the "drug registration certificate" issued by the State Drug Administration, and its application for listing and registration of CD19 target auto car-t cell therapy product agilunsai injection was approved by the State Drug Administration.
Related companies: